Description: Young Investigator Awards aim to attract early career faculty with original ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders. Awardees will be provided funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects. Young Investigators are scientists within the first five years of their first academic faculty appointment. A mentorship commitment from a senior investigator is required.
Term: 3 Years
Amount: Up to $85,000 per year for three years (up to $255,000 total)
• Applicants must be within the first five years of their first independent, full time academic faculty appointment at the application deadline, at the level of Assistant Professor (or equivalent position);
• Applicants must designate at least one Mentor who is an established investigator at the same institution who will ensure that adequate support and guidance are provided for successful completion of the proposed research project and provide career mentorship. At least one Mentor with expertise in melanoma research is strongly advised;
• Applicants who have secured an independent full-time faculty position commencing by June 1, 2025 will be considered; in this case, a letter from an institutional official or department chairperson confirming the planned date of faculty appointment is required at the time of application;
• Applicants do not have to be on a tenure-track; however, fellows or others who are in training positions are not eligible to apply;
• Applicants who are in research support positions are not eligible to apply;
• Applicants who have been awarded a prior MRA Young Investigator Award are not eligible to apply for an additional MRA Young Investigator Award;
• Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle;
• All Young Investigator applicants must complete and return the Applicant Eligibility Checklist by October 21, 2024. Please email the completed checklist to Kris’tina Ackerman, MRA Operations & Grants Admin Coordinator at kackerman@curemelanoma.org.
Sponsor Institute/Organizations: Melanoma Research Alliance
Sponsor Type:
Address: 730 15th Street, NW Washington, DC 20005 (202) 336-8935 info@curemelanoma.org
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Nov 04, 2024
Nov 04, 2024
$85,000
up to 255,000
Affiliation: Melanoma Research Alliance
Address: 730 15th Street, NW Washington, DC 20005 (202) 336-8935 info@curemelanoma.org
Website URL: https://www.curemelanoma.org/research/request-for-proposals/mra-general-rfp
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.